A meta-analysis that shows breast cancer risk increases the longer women take hormone replacement therapy has revived longstanding debate over the safety of the treatment.
A meta-analysis that shows breast cancer risk increases the longer women take hormone replacement therapy has revived longstanding debate over the safety of the treatment.